ArticleNeuropharmacology2018

Juvenile treatment with mGluR2/3 agonist prevents schizophrenia-like phenotypes in adult by acting through GSK3β.

Bo Xing et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.